Skip to main content
SCYX
NASDAQ Life Sciences

SCYNEXIS to Execute 1-for-8 Reverse Stock Split to Regain Nasdaq Compliance

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.68
Mkt Cap
$58.096M
52W Low
$0.565
52W High
$1.31
52W Position info
20% above low
Off High info
48% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

SCYX sits 20% above its 52-week low of $0.565.

Summary

SCYNEXIS announced a 1-for-8 reverse stock split, effective May 29, 2026, with trading on a split-adjusted basis starting June 1. This follows shareholder approval on May 19, as outlined in previous proxy filings. The primary goal is to regain compliance with Nasdaq's minimum bid price requirement, reducing outstanding shares from approximately 79.5 million to 9.9 million. While crucial for continued listing, reverse splits are generally perceived negatively by the market, often indicating a company's struggle to maintain its stock price and potentially signaling underlying financial distress.

At the time of this announcement, SCYX was trading at $0.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.1M. The 52-week trading range was $0.57 to $1.31. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SCYX - Latest Insights

SCYX
Nov 05, 2026, 8:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.84
Real-time Price: $3.35 info
Change: -$0.490 (-13%) info
Market Cap: $32.834M info
SCYX
Oct 06, 2026, 7:53 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.18
Real-time Price: $3.35 info
Change: -$1.83 (-35%) info
Market Cap: $32.834M info
SCYX
Sep 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.71
Real-time Price: $3.35 info
Change: -$1.36 (-29%) info
Market Cap: $32.834M info
SCYX
Sep 28, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.46
Real-time Price: $3.35 info
Change: -$3.11 (-48%) info
Market Cap: $32.834M info
SCYX
Aug 10, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $3.35 info
Change: -$1.92 (-36%) info
Market Cap: $32.834M info